European Biotech Acquisition Corp. (EBAC)

NASDAQ: EBAC · IEX Real-Time Price · USD
+0.01 (0.10%)
Jun 24, 2022 4:00 PM EDT - Market closed
Market Cap 160.38M
Revenue (ttm) n/a
Net Income (ttm) 2.73M
Shares Out 16.40M
EPS (ttm) 0.14
PE Ratio 71.39
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,693
Open 9.78
Previous Close 9.77
Day's Range 9.78 - 9.78
52-Week Range 9.59 - 9.84
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About EBAC

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands. [Read more...]

Industry Blank Check / SPAC
IPO Date Mar 16, 2021
Employees 2
Stock Exchange NASDAQ
Ticker Symbol EBAC
Full Company Profile


European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report

NEW YORK--(BUSINESS WIRE)--European Biotech Acquisition Corp. receives expected notification from Nasdaq related to delayed quarterly report.